Sign In
Buy AGNPF
$0.248
-0.0513 (-17.12%)
At Close: Jul 31, 2026
Algernon Pharmaceuticals files pre-IND meeting request with FDA for Ifenprodil small cell lung cancer study
09:25am, Wednesday, 22'nd Sep 2021
Algernon Pharmaceuticals Inc announced it has filed a pre-IND (Investigational New Drug) meeting request with the US Food and Drug Administration (FDA) for its Ifenprodil small cell lung cancer study.
Algernon Pharmaceuticals Files U.S. FDA Pre-IND Meeting Request for Ifenprodil Small Cell Lung Cancer Study
07:30am, Wednesday, 22'nd Sep 2021
VANCOUVER, British Columbia, Sept. 22, 2021 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “Company” or “Algernon”) a clinical stage pharmac
Algernon Pharmaceuticals announces plans for a Phase 2 Ifenprodil chronic cough study in the US
08:52am, Monday, 20'th Sep 2021
Algernon Pharmaceuticals Inc. said that it plans to file a pre-Investigational New Drug (IND) meeting request with the US Food and Drug Administration (FDA) for its repurposed drug NP-120 (Ifenprodil)
VANCOUVER, British Columbia, Sept. 09, 2021 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “Company” or “Algernon”) a clinical stage pharmac
Algernon Pharmaceuticals appoints Harry Bloomfield QC to its board of director, says he has been elected chairman
07:29am, Thursday, 09'th Sep 2021
Algernon Pharmaceuticals Inc. has announced the appointment of Harry Bloomfield QC as a new member of its board of directors and said he has been elected chairman of the board.
Algernon Pharmaceuticals Confirms DMT Increased Growth of Neurons by 40% in Preclinical Study at Sub Hallucinogenic Dose
07:30am, Tuesday, 07'th Sep 2021
VANCOUVER, British Columbia, Sept. 07, 2021 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “Company” or “Algernon”) a clinical stage pharmac
Algernon Pharmaceuticals to study Ifenprodil's effectiveness in small cell lung cancer with research pioneer Dr William North
09:14am, Wednesday, 11'th Aug 2021
Algernon Pharmaceuticals Inc announced an expansive new research program that looks at the effects of NP-120, or Ifenprodil, on a particularly deadly form of lung cancer. The program zeroes in on sm
Algernon Pharmaceuticals unlocking the value of medicine through repurposed drugs
11:55am, Tuesday, 10'th Aug 2021
Drug repurposing model reduces risk and capital required Working to develop Ifenprodil for idiopathic pulmonary fibrosis and chronic cough Experienced management team What Algernon Pharmaceuticals doe
Algernon Pharmaceuticals hits 70% enrollment for Phase 2 clinical study of Ifenprodil for idiopathic pulmonary fibrosis and chronic cough
09:55am, Wednesday, 07'th Jul 2021
Algernon Pharmaceuticals Inc (CSE:AGN) (OTCQB:AGNPF) (FRA:AGW) has reached 70% of its enrollment target for its Phase 2 clinical study of its re-purposed drug NP-120 (Ifenprodil) for idiopathic pulmon
Algernon Pharmaceuticals Announces 70% Enrollment of its Ifenprodil IPF and Chronic Cough Phase 2 Human Study
07:30am, Wednesday, 07'th Jul 2021
VANCOUVER, British Columbia, July 07, 2021 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCB: AGNPF) (the “Company” or “Algernon”), a clinical stage pharmace
Algernon Pharmaceuticals Inc (CSE:AGN) (OTCQB:AGNPF) (FRA:AGW), the drug repurposing company, has revealed that it will not be advancing Ifenprodil into a Phase 3 clinical trial for coronavirus (COVID
Algernon Pharmaceuticals targets first human study for its DMT stroke program in 4Q 2021
08:34am, Thursday, 17'th Jun 2021
Algernon Pharmaceuticals Inc (CSE:AGN) (FRA:AGW) (OTCQB:AGNPF) has announced that all of the required permits and licenses for the manufacture of its AP-188 (N, N-Dimethyltryptamine or DMT) have been
Algernon Pharmaceuticals Targets First Human Study of its Psychedelic Drug DMT Stroke Program for Q4, 2021
07:00am, Thursday, 17'th Jun 2021
VANCOUVER, British Columbia, June 17, 2021 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “Company” or “Algernon”) is pleased to announce th
Dow pulls to above the flatline after morning struggles as traders digest jobs data
12:35pm, Thursday, 03'rd Jun 2021
12:30pm: Nasdaq finds little upward momentum The Dow clawed its way out of an early deficit to 15 points higher at midday at 34,615. The Nasdaq was down 117 points, 0.9%, at 13,641, and the S&P 500 sh
Algernon Pharmaceuticals expands Ifenprodil research to pancreatic cancer in new clinical study
09:28am, Thursday, 03'rd Jun 2021
Algernon Pharmaceuticals Inc (CSE:AGN) (OTCQB:AGNPF) (FRA:AGW) is expanding its investigation into the use of Ifenprodil in pancreatic cancer with a new clinical research program. Previous studies h
